Share

By Date


  • 27-February-2019

    English

    OECD Competition Open Day 2019

    27 February 2019 - Debates at the inaugural OECD Competition Open Day will address: non-price competition in digital markets; vertical restraints and exclusionary practices in e-commerce; excessive prices in pharmaceutical markets; and, gun jumping and pre-closing exchanges of information.

    Related Documents
  • 4-December-2018

    English

    Concentration in Seed Markets - Potential Effects and Policy Responses

    Recent mergers in the seed industry have led to concerns about market concentration and its potential effects on prices, product choice, and innovation. This study provides new and detailed empirical evidence on the degree of market concentration in seed and GM technology across a broad range of crops and countries, and analyses the causes and potential effects of concentration. It also explains how competition authorities have responded to mergers, and suggests policy options to help safeguard and stimulate competition and innovation in plant breeding by avoiding unnecessary regulatory barriers, by facilitating access to genetic resources and intellectual property, as well as by stimulating public and private R&D. As this study shows, policy makers have several levers besides competition policy to ensure an innovative and competitive seed industry.
  • 30-November-2018

    English

    A Chain Reaction: Disruptive Innovation in the Electricity Sector

    This report explores the impact of innovative technologies on the electricity sector and examines priorities for regulatory policies that governments will need to put in place to negotiate the energy transition to a zero-carbon economy.

    Related Documents
  • 29-November-2018

    English

    OECD Global Forum on Competition

    Paris, 29-30 November 2018: The 2018 Global Forum will focus on: competition and fairer societies; gender; regional competition agreements; investigative powers; and state-owned enterprises.

    Related Documents
  • 28-November-2018

    English

    Excessive Pricing in Pharmaceuticals

    A number of competition enforcement actions against excessive pricing have taken place in the pharmaceutical sector, despite competition authorities usually being reluctant to intervene directly against high prices. In November 2018, the OECD held a discussion on the intersection of competition concerns with excessive prices and the interaction between competition and regulated sectors such as pharma.

    Related Documents
  • 28-November-2018

    English

    Personalised Pricing in the Digital Era

    As data analytics and pricing algorithms become common business practice in the digital era, there are growing concerns about the possibility that companies use such tools to engage in personalised pricing. In November 2018, the OECD Consumer Protection and Competition committees jointly discussed challenges associated with the ambiguous and multi-dimensional effects of personalised pricing among other issues.

    Related Documents
  • 28-November-2018

    English

    Quality considerations in the zero-price economy

    Zero-price products are not a new concept and over the course of a single day, most consumers will come into contact with at least one product that is offered to them at a price of zero. In the digital economy, however, new zero-price markets have arisen. In November 2018 the OECD held a discussion to study their own unique characteristics and challenges they may impose. This page contains all related materials.

    Related Documents
  • 27-November-2018

    English

    Gun jumping and suspensory effects of merger notifications

    Gun jumping has received a lot of attention recently, as a perception has arisen that competition authorities are devoting more enforcement resources to these violations, and that the amounts of monetary fines for such infringements are increasing. In November 2018, the OECD held a roundtable to discuss recent developments in the enforcement practice, and contrast them with business needs in various stages before closing a merger.

    Related Documents
  • 26-November-2018

    English

    Designing publicly funded healthcare markets

    While there is little guidance on where or how to introduce choice and competition in healthcare services, there has nevertheless been a steady movement towards the greater use of market mechanisms to improve their quality and efficiency. In November 2018, the OECD held a discussion to share experiences and lessons learned on the topic. This page contains all related materials.

    Related Documents
  • 26-November-2018

    English

    Treatment of legally privileged information in competition proceedings

    Different approaches to legal professional privilege among jurisdictions create challenges regarding companies’ international operations, and authorities’ co-operation and sharing of information in cross-border cases involving jurisdictions offering dissimilar levels of protection. This November 2018 OECD discussion dealt with these questions.

    Related Documents
  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>